Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021:43:e2021011.
doi: 10.4178/epih.e2021011. Epub 2021 Feb 3.

Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis

Dan Huang et al. Epidemiol Health. 2021.

Abstract

Objectives: Biliary tract cancers (BTCs) are rare but highly fatal. Although the etiology of BTC is poorly understood, gallstones are proposed to be a major risk factor. We conducted a systematic review and meta-analysis to examine the associations between gallstone characteristics and BTC risk.

Methods: We searched the MEDLINE, Embase, and Cochrane Central databases and systematically reviewed cohort and case-control studies published before April 9, 2018. All the included studies reported appropriate risk estimates and confidence intervals (CIs) for associations between the presence, size, number, or duration of gallstones and the risk of BTC, including gallbladder cancer (GBC), extrahepatic bile duct cancer (EBDC), and ampulla of Vater cancer (AOVC). Summary odds ratios (ORs) and their 95% CIs were calculated using a random-effects model in the meta-analysis. Subgroup analyses were conducted to inspect sources of potential heterogeneity, and the Egger test was performed to assess publication bias.

Results: Seven cohort studies and 23 case-control studies in Asian, European, and American populations were included. The presence of gallstones was associated with an increased risk of BTC (OR, 4.38; 95% CI, 3.23 to 5.93; I2=91.2%), GBC (OR, 7.26; 95% CI, 4.33 to 12.18), EBDC (OR, 3.17; 95% CI, 2.24 to 4.50), and AOVC (OR, 3.28; 95% CI, 1.33 to 8.11). Gallstone size (>1 vs. <1 cm; OR, 1.88; 95% CI, 1.10 to 3.22) was significantly associated with the risk of GBC.

Conclusions: Gallstone characteristics, such as presence, size, and number, are associated with an increased risk of BTC. However, significantly high heterogeneity in the meta-analyses is a limitation of this study.

Keywords: Ampulla of Vater; Bile duct neoplasms; Biliary tract neoplasms; Cholangiocarcinoma; Gallbladder neoplasms; Gallstones.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare for this study.

Figures

Figure 1.
Figure 1.
Flow chart of study selection for the meta-analysis.
Figure 2.
Figure 2.
Forest plot showing the relationship between presence of gallstone and the risk of BTC. 1OR (95% CI) refers to the estimate of effects included in a random-effects model. 2Effect size of Lai et al. [27] was calculated by pooling the results of DM group and non-DM group. 3Effect size of Lowenfels et al. [29] was calculated by pooling the results of Indian and non-Indian. 4Pooled the results of three types BTC subsites. 5Pooled the results of two types BTC subsites. The numbers are arranged in the order of Table 1. OR, odds ratio; CI, confidence interval; GBC, gallbladder cancer; CCA, cholangiocarcinoma; BTC, biliary tract cancer; EBDC, extrahepatic bile duct cancer; AOVC, ampulla of Vater cancer; DM, diabetes mellitus.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
    1. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, et al. Cancer incidence in five continents Vol. X. 2014 [cited 2020 Dec 1]. Available from: https://ci5.iarc.fr/CI5I-X/old/vol10/CI5vol10.pdf. - PubMed
    1. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019;51:417–430. - PMC - PubMed
    1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–125. - PubMed
    1. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146–159. - PubMed

LinkOut - more resources